Last 7 days
-0.2%
Last 30 days
2.8%
Last 90 days
46.7%
Trailing 12 Months
-27.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 38.9B | 6.8B | -7.12% | -2.94% | 31.04 | 5.68 | 8.37% | 3.64% |
ILMN | 34.8B | 4.6B | 9.07% | -35.87% | -7.89 | 7.58 | 1.28% | -677.95% |
MTD | 32.3B | 3.9B | 0.30% | 5.82% | 37.04 | 8.24 | 5.43% | 13.46% |
WAT | 17.7B | 3.0B | -6.58% | -7.74% | 25.05 | 5.97 | 6.68% | 2.15% |
PKI | 16.1B | 3.3B | -0.99% | -28.86% | 28.31 | 4.87 | -34.64% | -39.65% |
MID-CAP | ||||||||
SMALL-CAP | ||||||||
PACB | 2.2B | 128.3M | 3.11% | -0.62% | -6.93 | 16.97 | -1.69% | -73.40% |
ADPT | 1.2B | 185.3M | -4.53% | -36.18% | -6.03 | 6.51 | 20.06% | 3.42% |
NSTG | 404.1M | 127.3M | -11.64% | -74.22% | -2.53 | 3.18 | -12.28% | -38.43% |
QTRX | 394.4M | 105.5M | -10.11% | -62.94% | -4.08 | 3.74 | -4.55% | -67.63% |
BNGO | 326.9M | 27.8M | -22.54% | -54.36% | -2.47 | 11.76 | 54.62% | -83.06% |
CDXS | 255.3M | 138.6M | -29.45% | -81.04% | -7.6 | 1.84 | 32.30% | -57.86% |
HBIO | 130.5M | 113.3M | 8.01% | -46.55% | -13.71 | 1.15 | -4.68% | -3204.17% |
PSNL | 121.4M | 65.0M | -18.24% | -68.45% | -1.07 | 1.87 | -23.92% | -73.73% |
CSBR | 57.9M | 54.1M | -2.96% | -46.49% | 536.06 | 1.07 | 21.80% | -72.38% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 2.5% | 516,409,000 | 503,707,000 | 497,932,000 | 499,165,000 | 490,490,000 |
Gross Profit | 0.9% | 396,023,000 | 392,550,000 | 392,634,000 | 416,656,000 | 416,399,000 |
Operating Expenses | 1.9% | 563,967,000 | 553,228,000 | 529,195,000 | 500,428,000 | 468,652,000 |
S&GA Expenses | 3.1% | 298,300,000 | 289,290,000 | 277,965,000 | 267,331,000 | 257,560,000 |
EBITDA | 0.2% | -136,127,000 | -136,357,000 | -113,325,000 | -60,963,000 | -31,731,000 |
EBITDA Margin | 2.6% | -0.26 | -0.27 | -0.23 | -0.12 | -0.06 |
Earnings Before Taxes | -0.3% | -161,971,000 | -161,553,000 | -138,166,000 | -84,293,000 | -53,715,000 |
EBT Margin | 2.2% | -0.31 | -0.32 | -0.28 | -0.17 | -0.11 |
Interest Expenses | -16.2% | 476,000 | 568,000 | 673,000 | 773,000 | 866,000 |
Net Income | 0.7% | -166,000,000 | -167,234,000 | -142,491,000 | -89,085,000 | -58,223,000 |
Net Income Margin | 3.2% | -0.32 | -0.33 | -0.29 | -0.18 | -0.12 |
Free Cahsflow | -2.6% | -165,267,000 | -161,069,000 | -161,376,000 | -128,642,000 | -122,651,000 |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 3.3% | 1,029 | 996 | 1,002 | 1,003 | 1,019 |
Current Assets | 0.9% | 635 | 629 | 666 | 697 | 748 |
Cash Equivalents | -5.9% | 227 | 242 | 282 | 320 | 596 |
Inventory | 3.8% | 82.00 | 79.00 | 71.00 | 64.00 | 60.00 |
Net PPE | 12.3% | 289 | 258 | 223 | 190 | 169 |
Goodwill | 0% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Liabilities | 1.3% | 223 | 220 | 218 | 197 | 201 |
Current Liabilities | 3.2% | 131 | 127 | 118 | 94.00 | 110 |
Shareholder's Equity | 3.9% | 806 | 776 | 784 | 807 | 818 |
Retained Earnings | -1.7% | -1,029 | -1,012 | -970 | -905 | -863 |
Additional Paid-In Capital | 2.6% | 1,839 | 1,793 | 1,758 | 1,715 | 1,681 |
Accumulated Depreciation | 40.4% | 69.00 | 49.00 | - | - | - |
Shares Outstanding | 0.9% | 115 | 114 | 114 | 113 | 113 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 19.1% | -33.61 | -41.52 | -58.18 | -38.09 | -21.37 |
Share Based Compensation | 11.5% | 137 | 123 | 115 | 106 | 96.00 |
Cashflow From Investing | -1.6% | -350 | -345 | -332 | -319 | -106 |
Cashflow From Financing | -19.8% | 16.00 | 20.00 | 24.00 | 34.00 | 35.00 |
86.6%
64.0%
58.1%
Y-axis is the maximum loss one would have experienced if 10x Genomics was unfortunately bought at previous high price.
-4.2%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | BAILLIE GIFFORD & CO | added | 1.88 | 72,998,400 | 313,465,000 | 0.33% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.05 | 76,760 | 353,760 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 319 | 358,000 | 439,000 | -% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 4.78 | 332,981 | 1,309,980 | 0.08% |
2023-02-28 | Voya Investment Management LLC | added | 0.01 | 282,450 | 1,290,450 | -% |
2023-02-24 | NATIXIS | new | - | 74,155 | 74,155 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 555,000 | 2,547,000 | 0.03% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -8.51 | 1,402 | 9,402 | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | - | -25,000 | - | -% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | reduced | -7.41 | -89.00 | 911 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | venrock associates vi, l.p. | 4.9% | 4,828,247 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.81% | 8,420,011 | SC 13G/A | |
Feb 08, 2023 | morgan stanley | 10.4% | 9,894,979 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 5.6% | 5,319,179 | SC 13G/A | |
Jan 18, 2023 | baillie gifford & co | 9.00% | 8,602,235 | SC 13G/A | |
Sep 12, 2022 | morgan stanley | 10.9% | 10,341,753 | SC 13G/A | |
May 09, 2022 | blackrock inc. | 10.9% | 10,227,673 | SC 13G | |
Feb 14, 2022 | venrock associates vi, l.p. | 5.1% | 4,828,247 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.25% | 7,554,042 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 2.48 -95.06% | 3.37 -93.29% | 6.07 -87.92% | 10.16 -79.77% | 13.70 -72.73% |
Current Inflation | 2.42 -95.18% | 3.20 -93.63% | 5.55 -88.95% | 9.05 -81.98% | 12.07 -75.97% |
Very High Inflation | 2.33 -95.36% | 3.00 -94.03% | 4.93 -90.19% | 7.75 -84.57% | 10.19 -79.71% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 23, 2023 | 4 | Insider Trading | |
Mar 23, 2023 | 4 | Insider Trading | |
Mar 23, 2023 | 4 | Insider Trading | |
Mar 23, 2023 | 4 | Insider Trading | |
Mar 16, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Feb 24, 2023 | 4 | Insider Trading | |
Feb 24, 2023 | 4 | Insider Trading | |
Feb 24, 2023 | 4 | Insider Trading | |
Feb 16, 2023 | 10-K | Annual Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-21 | Saxonov Serge | acquired | - | - | 36,387 | chief executive officer |
2023-03-21 | Hindson Benjamin J. | acquired | - | - | 36,387 | see remarks |
2023-03-21 | Wilbur James | acquired | - | - | 14,555 | chief commercial officer |
2023-03-21 | McAnear Justin J. | acquired | - | - | 25,991 | chief financial officer |
2023-03-14 | Saxonov Serge | sold | -97,755 | 48.8779 | -2,000 | chief executive officer |
2023-03-07 | Saxonov Serge | gifted | - | - | -260 | chief executive officer |
2023-02-22 | Saxonov Serge | sold | -92,689 | 47.7533 | -1,941 | chief executive officer |
2023-02-22 | McAnear Justin J. | sold | -59,452 | 47.7533 | -1,245 | chief financial officer |
2023-02-22 | Hindson Benjamin J. | sold | -83,186 | 47.7533 | -1,742 | see remarks |
2022-12-14 | Hindson Benjamin J. | acquired | 172,701 | 5.04 | 34,266 | see remarks |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 516,409 | $ 490,490 | $ 298,845 |
Cost of revenue | 120,386 | 74,091 | 58,468 |
Gross profit | 396,023 | 416,399 | 240,377 |
Operating expenses: | |||
Research and development | 265,667 | 211,752 | 123,375 |
In-process research and development | 0 | 0 | 447,548 |
Selling, general and administrative | 298,300 | 257,560 | 202,326 |
Accrued contingent liabilities | 0 | (660) | 1,270 |
Total operating expenses | 563,967 | 468,652 | 774,519 |
Loss from operations | (167,944) | (52,253) | (534,142) |
Other income (expense): | |||
Interest income | 6,647 | 206 | 1,532 |
Interest expense | (476) | (866) | (1,682) |
Other (expense) income, net | (198) | (802) | 1,337 |
Loss on extinguishment of debt | 0 | 0 | (1,521) |
Total other income (expense) | 5,973 | (1,462) | (334) |
Loss before provision for income taxes | (161,971) | (53,715) | (534,476) |
Provision for income taxes | 4,029 | 4,508 | 8,255 |
Net loss | $ (166,000) | $ (58,223) | $ (542,731) |
Net loss per share, basic (in dollars per share) | $ (1.46) | $ (0.53) | $ (5.37) |
Net loss per share, diluted (in dollars per share) | $ (1.46) | $ (0.53) | $ (5.37) |
Weighted-average shares used to compute net loss per share, basic (in shares) | 113,858,684 | 110,347,937 | 101,151,675 |
Weighted-average shares used to compute net loss per share, diluted (in shares) | 113,858,684 | 110,347,937 | 101,151,675 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 219,746 | $ 587,447 |
Marketable securities | 210,238 | 0 |
Restricted cash | 2,633 | 1,028 |
Accounts receivable, net | 104,211 | 85,254 |
Inventory | 81,629 | 59,966 |
Prepaid expenses and other current assets | 16,578 | 13,896 |
Total current assets | 635,035 | 747,591 |
Property and equipment, net | 289,328 | 169,492 |
Restricted cash | 4,974 | 7,598 |
Operating lease right-of-use assets | 69,882 | 60,918 |
Goodwill | 4,511 | 4,511 |
Intangible assets, net | 22,858 | 25,397 |
Other noncurrent assets | 2,392 | 3,319 |
Total assets | 1,028,980 | 1,018,826 |
Current liabilities: | ||
Accounts payable | 21,599 | 17,351 |
Accrued compensation and related benefits | 32,675 | 31,626 |
Accrued expenses and other current liabilities | 59,779 | 50,909 |
Deferred revenue | 7,867 | 5,340 |
Operating lease liabilities | 9,037 | 5,131 |
Total current liabilities | 130,957 | 110,357 |
Accrued license fee, noncurrent | 0 | 5,814 |
Operating lease liabilities, noncurrent | 86,139 | 76,847 |
Other noncurrent liabilities | 6,141 | 8,240 |
Total liabilities | 223,237 | 201,258 |
Commitments and contingencies (Note 7) | ||
Stockholders' equity: | ||
Preferred stock, $0.00001 par value; 100,000,000 shares authorized, no shares issued or outstanding as of December 31, 2022 and December 31, 2021 | 0 | 0 |
Common stock, $0.00001 par value; 1,100,000,000 shares authorized (Class A 1,000,000,000, Class B 100,000,000); 115,195,009 (Class A 96,527,754, Class B 18,667,255) and 112,514,977 (Class A 92,868,512, Class B 19,646,465) shares issued and outstanding as of December 31, 2022 and 2021 | 2 | 2 |
Additional paid-in capital | 1,839,397 | 1,680,865 |
Accumulated deficit | (1,029,321) | (863,321) |
Accumulated other comprehensive income (loss) | (4,335) | 22 |
Total stockholders’ equity | 805,743 | 817,568 |
Total liabilities and stockholders’ equity | $ 1,028,980 | $ 1,018,826 |